These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7694946)

  • 1. Sneddon's syndrome--an inflammatory disorder of small arteries followed by smooth muscle proliferation. Immunohistochemical and ultrastructural evidence.
    Sepp N; Zelger B; Schuler G; Romani N; Fritsch P
    Am J Surg Pathol; 1995 Apr; 19(4):448-53. PubMed ID: 7694946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Life history of cutaneous vascular lesions in Sneddon's syndrome.
    Zelger B; Sepp N; Schmid KW; Hintner H; Klein G; Fritsch PO
    Hum Pathol; 1992 Jun; 23(6):668-75. PubMed ID: 1592390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical characterization of the 'intimal proliferation' phenomenon in Sneddon's syndrome and essential thrombocythaemia.
    Tamm E; Jungkunz W; Wolter M; Marsch WC
    Br J Dermatol; 1994 Dec; 131(6):814-21. PubMed ID: 7857833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sneddon's syndrome as a disorder of small arteries with endothelial cells proliferation: ultrastructural and neuroimaging study.
    Lewandowska E; Wierzba-Bobrowicz T; Wagner T; Bogusławska R; Rudnicka A; Leszczyńska A; Pasennik E; Lechowicz W; Stepień T; Kuran W
    Folia Neuropathol; 2005; 43(4):345-54. PubMed ID: 16416398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sneddon's syndrome: a systemic arterio-occlusive disorder.
    al Meshari K; al Eisa A; Akhtar M
    Am J Kidney Dis; 1995 Aug; 26(2):368-72. PubMed ID: 7645543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sneddon's syndrome: diagnosis by skin biopsy and MRI in 17 patients.
    Stockhammer G; Felber SR; Zelger B; Sepp N; Birbamer GG; Fritsch PO; Aichner FT
    Stroke; 1993 May; 24(5):685-90. PubMed ID: 8488523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Livedo racemosa generalisata. Clinical aspects and histopathology of obliterating arteriolopathy with CNS involvement].
    Marsch WC; Muckelmann R
    Z Hautkr; 1985 Jun; 60(11):873-4. PubMed ID: 4013457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smooth muscle cell proliferation and localization of macrophages and T cells in the occlusive intracranial major arteries in moyamoya disease.
    Masuda J; Ogata J; Yutani C
    Stroke; 1993 Dec; 24(12):1960-7. PubMed ID: 7902623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generalized racemose livedo with cerebrovascular lesions (Sneddon syndrome): an occlusive arteriolopathy due to proliferation and migration of medial smooth muscle cells.
    Marsch WC; Muckelmann R
    Br J Dermatol; 1985 Jun; 112(6):703-8. PubMed ID: 4005168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combination of livedo racemosa, occlusion of cerebral blood vessels, and nephropathy: kidney involvement in Sneddon's syndrome.
    Ohtani H; Imai H; Yasuda T; Wakui H; Komatsuda A; Hamai K; Miura AB
    Am J Kidney Dis; 1995 Sep; 26(3):511-5. PubMed ID: 7645561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sneddon's syndrome. A long-term follow-up of 21 patients.
    Zelger B; Sepp N; Stockhammer G; Dosch E; Hilty E; Ofner D; Aichner F; Fritsch PO
    Arch Dermatol; 1993 Apr; 129(4):437-47. PubMed ID: 8466214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sneddon's syndrome: an unusual cause of cerebral infarct at a relatively young age].
    Canta LR; Koedijk FH; Tijssen CC
    Ned Tijdschr Geneeskd; 1994 May; 138(19):963-7. PubMed ID: 8196791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial Sneddon's syndrome.
    Mascarenhas R; Santo G; Gonçalo M; Ferro MA; Tellechea O; Figueiredo A
    Eur J Dermatol; 2003; 13(3):283-7. PubMed ID: 12804991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of anti-endothelial cell antibodies in patients with Sneddon's syndrome.
    Francès C; Le Tonquèze M; Salohzin KV; Kalashnikova LA; Piette JC; Godeau P; Nasonov EL; Youinou P
    J Am Acad Dermatol; 1995 Jul; 33(1):64-8. PubMed ID: 7601948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sneddon's syndrome.
    Stephens CJ
    Clin Exp Rheumatol; 1992; 10(5):489-92. PubMed ID: 1458702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sneddon syndrome].
    Richard MA; Grob JJ; Durand JM; Noë C; Basseres N; Bonerandi JJ
    Ann Dermatol Venereol; 1994; 121(4):331-7. PubMed ID: 7702255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sneddon's syndrome vasculopathy with antiphospholipid antibodies in a child].
    Villaizán C; Ferrada MJ; Legarda I; Iriarte J; Narbona J; Martínez-Lage JM
    Neurologia; 1995 Jan; 10(1):41-5. PubMed ID: 7893511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticardiolipin antibodies in Sneddon's syndrome.
    Kalashnikova LA; Nasonov EL; Kushekbaeva AE; Gracheva LA
    Neurology; 1990 Mar; 40(3 Pt 1):464-7. PubMed ID: 2314589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sneddon's syndrome with granulomatous leptomeningeal infiltration.
    Boortz-Marx RL; Clark HB; Taylor S; Wesa KM; Anderson DC
    Stroke; 1995 Mar; 26(3):492-5. PubMed ID: 7886731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sneddon's syndrome: generalized livedo reticularis and cerebrovascular disease. Importance of hemostatic screening.
    Devos J; Bulcke J; Degreef H; Michielsen B
    Dermatology; 1992; 185(4):296-9. PubMed ID: 1477426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.